{"url_path":"/sec/pmi/8-k/2026-07-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events. **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001437749-26-022589-index.html","accession_number":"0001437749-26-022589","cik":"0002030617","ticker":"PMI","issuer_name":"Picard Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001437749-26-022589-index.html","primary_entity_key":"0002030617","primary_entity_name":"Picard Medical, Inc."},"word_count":93,"has_tables":true,"body_markdown":"**Item 8.01 Other Events. **\n\n \n\nAs previously disclosed in Picard Medical, Inc.'s (the \"Company\") Current Report on Form 8-K filed on July 2, 2026, the Company published a pre-recorded presentation (the “Presentation”) providing stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The Presentation is incorporated herein by reference. A copy of the transcript for the Presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference."}